SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 45 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | -29.5% | 13,620 | -0.8% | 0.00% | – |
| Q2 2022 | $44,000 | -77.0% | 13,732 | -65.4% | 0.00% | -100.0% |
| Q1 2022 | $191,000 | -54.6% | 39,692 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $421,000 | -31.2% | 47,181 | +11.2% | 0.00% | 0.0% |
| Q3 2021 | $612,000 | +31.3% | 42,413 | +31.4% | 0.00% | 0.0% |
| Q2 2021 | $466,000 | -21.2% | 32,271 | -25.3% | 0.00% | -50.0% |
| Q1 2021 | $591,000 | – | 43,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |